Skin and soft tissue infections in biological therapy for psoriasis—A case report and systematic review of the literature
出版年份 2021 全文链接
标题
Skin and soft tissue infections in biological therapy for psoriasis—A case report and systematic review of the literature
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF DERMATOLOGY
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2021-06-04
DOI
10.1111/ijd.15679
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Risk of Serious Infection in Patients Receiving Systemic Medications for the Treatment of Psoriasis
- (2019) Erica D. Dommasch et al. JAMA Dermatology
- Real world data from the use of secukinumab in the treatment of moderate‐to‐severe psoriasis, including scalp and palmoplantar psoriasis: A 104‐week clinical study
- (2019) Natalia Rompoti et al. Dermatologic Therapy
- Female patients are less satisfied with biological treatment for psoriasis and experience more side‐effects than male patients: results from the prospective BioCAPTURE registry
- (2019) L.S. van der Schoot et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Initial Results of Secukinumab Drug Survival in Patients with Psoriasis: A Multicentre Daily Practice Cohort Study
- (2018) J Reek et al. ACTA DERMATO-VENEREOLOGICA
- Safety of biological therapies in ulcerative colitis: An umbrella review of meta-analyses
- (2018) Stefanos Bonovas et al. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- S3 Guideline for the treatment of psoriasis vulgaris, update - Short version part 1 - Systemic treatment
- (2018) Alexander Nast et al. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT
- Risk of Serious Infection in Patients with Psoriasis Receiving Biologic Therapies: A Prospective Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)
- (2018) Zenas Z.N. Yiu et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Infliximab is associated with an increased risk of serious infection in patients with psoriasis in the United Kingdom and Republic of Ireland: results from the British Association of Dermatologists Biologic Interventions Register (BADBIR)
- (2018) Z.Z.N. Yiu et al. BRITISH JOURNAL OF DERMATOLOGY
- Risk of Serious Infection among Patients Receiving Biologics for Chronic Inflammatory Diseases: Usefulness of Administrative Data
- (2018) Luca Quartuccio et al. Journal of Advanced Research
- Efficacy and safety of secukinumab in Taiwanese patients with moderate to severe plaque psoriasis: Subanalysis from ERASURE phase III study
- (2017) Nan-Lin Wu et al. JOURNAL OF DERMATOLOGY
- Serious infections among a large cohort of subjects with systemically treated psoriasis
- (2017) Allison S. Dobry et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Short- and long-term safety outcomes with ixekizumab from 7 clinical trials in psoriasis: Etanercept comparisons and integrated data
- (2017) Bruce Strober et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Risk of serious infections, cutaneous bacterial infections, and granulomatous infections in patients with psoriasis treated with anti–tumor necrosis factor agents versus classic therapies: Prospective meta-analysis of Psonet registries
- (2017) Ignacio Garcia-Doval et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Brodalumab, a human anti-interleukin-17-receptor antibody in the treatment of Japanese patients with moderate-to-severe plaque psoriasis: Efficacy and safety results from a phase II randomized controlled study
- (2016) Hidemi Nakagawa et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Bacterial Skin and Soft Tissue Infections in Adults: A Review of Their Epidemiology, Pathogenesis, Diagnosis, Treatment and Site Of Care
- (2016) Vincent Ki et al. Canadian Journal of Infectious Diseases & Medical Microbiology
- Long-term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate-to-severe psoriasis: results from the PHOENIX 2 study through 5 years of follow-up
- (2015) R.G. Langley et al. BRITISH JOURNAL OF DERMATOLOGY
- Anti–IL-23A mAb BI 655066 for treatment of moderate-to-severe psoriasis: Safety, efficacy, pharmacokinetics, and biomarker results of a single-rising-dose, randomized, double-blind, placebo-controlled trial
- (2015) James G. Krueger et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Risk of serious infection in biological treatment of patients with rheumatoid arthritis: a systematic review and meta-analysis
- (2015) Jasvinder A Singh et al. LANCET
- Risk of Serious Infection With Biologic and Systemic Treatment of Psoriasis
- (2015) Robert E. Kalb et al. JAMA Dermatology
- Psoriasis Severity and the Prevalence of Major Medical Comorbidity
- (2013) Howa Yeung et al. JAMA Dermatology
- Efficacy and safety of biologics in erythrodermic psoriasis: a multicentre, retrospective study
- (2012) M. Viguier et al. BRITISH JOURNAL OF DERMATOLOGY
- Safety of treatment with biologics for psoriasis in daily practice: 5-year data
- (2011) P.P.M. van Lümig et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Biologic therapies for psoriasis: practical experience in a U.K. tertiary referral centre
- (2008) R.B. Warren et al. BRITISH JOURNAL OF DERMATOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started